Disseminating immunological developments on a worldwide basis, Immunological Investigations provides a truly in-depth examination of the latest advances in molecular and cellular immunology by reporting on all facets of fundamental and applied immunology that include (but are not limited to): the development, activation and control of innate and adaptive immune cells, immunity to infectious diseases and cancer, transplantation, allergy, autoimmunity, immunodeficiencies, vaccines and immunotherapies, the interaction between the microbiome or metabolic diseases and immune function, mucosal immunity, aging and immunity, immune regulation of cardiovascular and neurological diseases, immunogenetics, immunohematology, and immunological techniques. Investigators are encouraged to submit original research articles that report novel findings, as well as review articles that cover new and emerging topics.
Immunological Investigations accepts Research Articles, Review Articles, Method Articles and Data Notes for publication.
Immunological Investigations operates a single-anonymized peer review policy.
Journal metrics
Usage
62K annual downloads/views
Citation metrics
2.9 (2023) Impact Factor
2.6 (2023) 5 year IF
5.5 (2023) CiteScore (Scopus)
0.552 (2023) SNIP
0.654 (2023) SJR
Speed/acceptance
3 days avg. from submission to first
decision
34 days avg. from submission to first
post-review decision
15 days avg. from acceptance to online
publication
16% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
EDITOR-in-CHIEF Adam Adler - Department of Immunology, UConn Health, Farmington, CT, USA Email: [email protected]
ASSOCIATE EDITOR Aimin Jiang - Henry Ford Health System, USA
EDITORIAL ADVISORY BOARD
Tom Alexander - Northeast Ohio Medical University, Rootstown, OH, USA Dan Amsterdam - University at Buffalo, Buffalo, NY, USA Jenna Bartley - UConn Health, Farmington, CT, USA John D. Colgan – University of Iowa, IA, USA Ernesto G. Denardin - University at Buffalo, Buffalo, NY, USA Rosemary D. Dziak - University at Buffalo, Buffalo, NY, USA Nejat Egilmez - University of Louisville, Louisville, KY, USA Lee Garrett-Sinha - University at Buffalo, Buffalo, NY, USA Aaron Glass- SUNY Upstate Medical University, Syracuse, NY, USA Abdel R. Hamad - Johns Hopkins School of Medicine, Baltimore, MD, USA Richard C. Koya - University of Chicago, Chicago, IL, USA Chen Liu - Peking University People's Hospital, Beijing, CHINA Phillip T. Loverde - UT Health San Antonio, San Antonio, TX, USA Lucy D. Mastrandea - University at Buffalo, Buffalo, NY USA Ross Molinaro - Siemens Healthcare Diagnostics Inc., Newark, DE, USA Roald Nezlin - The Weizmann Institute of Science, Rehovot, Israel Adekunle Odunsi - Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA Barbara E. Ostrov - Albany Medical Center, Albany, NY, USA Elizabeth Repasky - Roswell Park Cancer Institute, Buffalo, NY, USA Jacques Robert - University of Rochester Medical Center, Rochester, NY, USA Stanley Schwartz - University of Chicago, Chicago, IL, USA Yasmin Thanavala - Roswell Park Cancer Institute, Buffalo, NY, USA Li Lily Wang – Case Western Reserve University School of Medicine, OH, USA Chuanlai Xu - Jiangnan University, Wuxi, CHINA
EDITOR EMERITUS Kate Rittenhouse-Olson - University at Buffalo, Buffalo, NY, USA
Abstracting and indexing
Immunological Investigations is abstracted/indexed in:
Adis International Ltd. - Pharmacoeconomics and Outcomes News (Online) - Reactions Weekly (Online)
CABI
EBSCOhost - Academic Search Alumni Edition/Complete/Elite/Premier/R&D - Advanced Placement Source - Biological Abstracts (Online) - Biomedical Reference Collection: Corporate Edition - Current Abstracts - Energy & Power Source - Science and Technology Collection - TOC Premier (Table of Contents)
Elsevier BV - BIOBASE - EMBASE, Priority
International Atomic Energy Agency - INIS Collection Search (International Nuclear Information System)
National Library of Medicine - PubMed/MEDLINE
Thomson Reuters - Biological Abstracts (Online) - BIOSIS Previews - Current Contents - Science Citation Index Expanded - Web of Science
VINITI RAN - Referativnyi Zhurnal
Open access
Immunological Investigations is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Immunological Investigations: A Journal of Molecular and Cellular Immunology
(1985 - current)
Formerly known as
Immunological Communications
(1972 - 1984)
Advertising information
Would you like to advertise in Immunological Investigations?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Immunological Investigations.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![BioTechniques: Stay up to date with the hottest topics in the life sciences...]({"type":"image" , "src" : "/sda/112459/journalad-promotion-biotechniques.png"})